• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Actavis plc (ACT)

    -NYSE
    265.39 Up 1.64(0.62%) Dec 19, 4:12PM EST
    |After Hours : 265.39 Down 0.00 (0.00%) Dec 19, 6:51PM EST
    Add to Portfolio
    Prev Close:263.75
    Open:263.75
    Bid:250.00 x 100
    Ask:267.68 x 100
    1y Target Est:304.72
    Beta:0.63
    Earnings Date:Feb 18 - Feb 23 (Est.)
    Day's Range:261.79 - 267.61
    52wk Range:163.67 - 272.75
    Volume:3,528,571
    Avg Vol (3m):3,100,980
    Market Cap:70.34B
    P/E (ttm):N/A
    EPS (ttm):-5.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACT

    Comparison

    Symbol% ChgMkt Cap
    ACTUp 0.62%70.34B
    MYLUp 1.20%21.52B
    NVSUp 0.04%228.83B
    TEVAUp 2.38%49.58B

    Key Statistics

    Forward P/E (1 yr):16.04
    P/S (ttm):5.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :13.55
    Quarterly EPS Est (Dec-14) :3.49
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):0.89

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Actavis plc, an integrated specialty pharmaceutical company, is engaged in the development, manufacture, marketing, sale, and distribution of pharmaceutical products in the Americas, Europe, the Middle East, Africa, Australia, and the Asia Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback